OBJECTIVEWe evaluated the impact of normothermic regional perfusion (NRP) on short- and mid-term outcomes of kidney transplantation (KT) using donation after circulatory death (DCD). We further examined the influence of NRP duration and identified subgroups most likely to benefit from its use.BACKGROUNDNRP has recently gained adoption in DCD-KT as a means to mitigate donor warm ischemic injury. However, its effect on graft and patient outcomes particularly beyond one year remains uncertain, and the role of NRP duration and subgroup-specific benefits has not been well defined.METHODSUsing UNOS STAR files, we analyzed 21,010 primary adult DCD-KT cases performed between 2020-2025. Based on prior literature, cases were classified as non-NRP (0-30 min from circulatory death to cross-clamp) or NRP (30-180 min). Propensity score matching (PSM) adjusted for donor and recipient differences. Kaplan-Meier methods assessed graft and patient survival.RESULTSAfter PSM, NRP was associated with reduced DGF (30.3% vs. 49.7%), shorter hospital stay (median 4 vs. 5 d), and improved overall graft and patient survival (P=0.007 and 0.047). No difference was observed in overall graft survival between short and long NRP durations (P=0.62). Subgroup analyses for one-year graft survival revealed that the benefit of NRP was more evident in cases of elderly recipients or donors, high donor BMI, higher KDPI, and prolonged pre-transplant dialysis.CONCLUSIONSNRP improved both short- and mid-term outcomes, including three-year/overall graft/patient survival. NRP duration did not significantly affect overall graft survival. The benefits of NRP were pronounced in high-risk subgroups.
{"title":"Impact of Normothermic Regional Perfusion on Clinical Outcomes in Kidney Transplantation from Donors After Circulatory Death: A US Nationwide Analysis of 38,048 Cases.","authors":"Jiro Kusakabe,Eduardo Fernandes,Khaled Refaai,Ahmed Hussein,Komal Kumar,Aza Abdalla,Shalini Saith,Salwa Rhazouani,Kazunari Sasaki,Neerja Agrawal,Antonio Pinna","doi":"10.1097/sla.0000000000007018","DOIUrl":"https://doi.org/10.1097/sla.0000000000007018","url":null,"abstract":"OBJECTIVEWe evaluated the impact of normothermic regional perfusion (NRP) on short- and mid-term outcomes of kidney transplantation (KT) using donation after circulatory death (DCD). We further examined the influence of NRP duration and identified subgroups most likely to benefit from its use.BACKGROUNDNRP has recently gained adoption in DCD-KT as a means to mitigate donor warm ischemic injury. However, its effect on graft and patient outcomes particularly beyond one year remains uncertain, and the role of NRP duration and subgroup-specific benefits has not been well defined.METHODSUsing UNOS STAR files, we analyzed 21,010 primary adult DCD-KT cases performed between 2020-2025. Based on prior literature, cases were classified as non-NRP (0-30 min from circulatory death to cross-clamp) or NRP (30-180 min). Propensity score matching (PSM) adjusted for donor and recipient differences. Kaplan-Meier methods assessed graft and patient survival.RESULTSAfter PSM, NRP was associated with reduced DGF (30.3% vs. 49.7%), shorter hospital stay (median 4 vs. 5 d), and improved overall graft and patient survival (P=0.007 and 0.047). No difference was observed in overall graft survival between short and long NRP durations (P=0.62). Subgroup analyses for one-year graft survival revealed that the benefit of NRP was more evident in cases of elderly recipients or donors, high donor BMI, higher KDPI, and prolonged pre-transplant dialysis.CONCLUSIONSNRP improved both short- and mid-term outcomes, including three-year/overall graft/patient survival. NRP duration did not significantly affect overall graft survival. The benefits of NRP were pronounced in high-risk subgroups.","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":"194 1","pages":""},"PeriodicalIF":9.0,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146005324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-21DOI: 10.1097/sla.0000000000007014
Matthias Pfister,Zhihao Li,Fariba Abbassi,Raphael L C Araujo,Vikram A Chaudhari,Rim Cherif,Laleh Foroutani,Fabio Giannone,Michael Ginesini,Abdallah Iben-Khayat,Boram Lee,Ricardo Nunez,Chie Takishita,Patrick W Underwood,Emanuel Vigia,Elaina Vivian,Yusuke Watanabe,Taiga Wakabayashi,Adnan Alseidi,Fabrizio Di Benedetto,Ugo Boggi,Raffaele Brustia,Tan-To Cheung,Mary E Dillhoff,Brian K P Goh,Ho-Seong Han,Benedetto Ielpo,Jae Hoon Lee,Marcel A Machado,John Martinie,Hugo Pinto Marques,Alejandro Mejia,Yuichi Nagakawa,Masafumi Nakamura,Patrick Pessaux,Patricio M Polanco,Olivier Saint-Marc,Shailesh V Shrikhande,Go Wakabayashi,Pierre-Alain Clavien
OBJECTIVETo establish international benchmark values for relevant outcome parameters in robotic Whipple.SUMMARY BACKGROUND DATAFor safe adoption of surgical innovation, robust quality control is essential. Benchmarking is a validated tool for assessing surgical performance. Recent international consensus identified establishing benchmark values for robotic Whipple as top priority.METHODSWe analyzed consecutive patients undergoing robotic Whipple between 2020-2023 with a minimum one-year follow-up. Reference centers were required to perform ≥15 cases/year, be scientifically active in the field, and maintain a prospective database. Benchmark criteria included benign or resectable malignant disease without neoadjuvant therapy, arterial resection, major co-morbidities, or significant previous abdominal surgery. Benchmarks were established for 13 outcome parameters.RESULTThe benchmark cohort comprised 418 patients from 12 centers across four continents. Benchmark values were: conversion rate ≤4.3%, transfusion rate ≤2.1%, 6-month mortality ≤2.2%, major complications ≤23.2%, and CCI® ≤20.9. Clinically relevant pancreatic fistula (grade B/C) and hemorrhage (grade B/C) rates were ≤23.6% and ≤12.7%, respectively. For pancreatic ductal adenocarcinoma (n=123), the benchmark for lymph node yield was ≥20. Higher surgical difficulty was associated with increased overall postoperative morbidity (R2=0.38, P=0.019), higher center caseload with reduced pancreas-specific complications (R2=0.28, P=0.044). Independent POPF predictors included duct diameter ≤4 mm (OR 1.37, 95% CI: 1.03, 1.82), anticoagulation (OR 2.45, 95% CI: 1.47, 3.99), and indication other than PDAC (OR 2.33, 95% CI: 1.68, 3.27).CONCLUSIONSThis study establishes the first international benchmarks for robotic Whipple, demonstrating oncologic outcomes and morbidity comparable to open surgery with the benefits of minimally invasive surgery.
{"title":"Setting the Standard in Robotic Whipple Surgery: International Multicenter Benchmark Analysis.","authors":"Matthias Pfister,Zhihao Li,Fariba Abbassi,Raphael L C Araujo,Vikram A Chaudhari,Rim Cherif,Laleh Foroutani,Fabio Giannone,Michael Ginesini,Abdallah Iben-Khayat,Boram Lee,Ricardo Nunez,Chie Takishita,Patrick W Underwood,Emanuel Vigia,Elaina Vivian,Yusuke Watanabe,Taiga Wakabayashi,Adnan Alseidi,Fabrizio Di Benedetto,Ugo Boggi,Raffaele Brustia,Tan-To Cheung,Mary E Dillhoff,Brian K P Goh,Ho-Seong Han,Benedetto Ielpo,Jae Hoon Lee,Marcel A Machado,John Martinie,Hugo Pinto Marques,Alejandro Mejia,Yuichi Nagakawa,Masafumi Nakamura,Patrick Pessaux,Patricio M Polanco,Olivier Saint-Marc,Shailesh V Shrikhande,Go Wakabayashi,Pierre-Alain Clavien","doi":"10.1097/sla.0000000000007014","DOIUrl":"https://doi.org/10.1097/sla.0000000000007014","url":null,"abstract":"OBJECTIVETo establish international benchmark values for relevant outcome parameters in robotic Whipple.SUMMARY BACKGROUND DATAFor safe adoption of surgical innovation, robust quality control is essential. Benchmarking is a validated tool for assessing surgical performance. Recent international consensus identified establishing benchmark values for robotic Whipple as top priority.METHODSWe analyzed consecutive patients undergoing robotic Whipple between 2020-2023 with a minimum one-year follow-up. Reference centers were required to perform ≥15 cases/year, be scientifically active in the field, and maintain a prospective database. Benchmark criteria included benign or resectable malignant disease without neoadjuvant therapy, arterial resection, major co-morbidities, or significant previous abdominal surgery. Benchmarks were established for 13 outcome parameters.RESULTThe benchmark cohort comprised 418 patients from 12 centers across four continents. Benchmark values were: conversion rate ≤4.3%, transfusion rate ≤2.1%, 6-month mortality ≤2.2%, major complications ≤23.2%, and CCI® ≤20.9. Clinically relevant pancreatic fistula (grade B/C) and hemorrhage (grade B/C) rates were ≤23.6% and ≤12.7%, respectively. For pancreatic ductal adenocarcinoma (n=123), the benchmark for lymph node yield was ≥20. Higher surgical difficulty was associated with increased overall postoperative morbidity (R2=0.38, P=0.019), higher center caseload with reduced pancreas-specific complications (R2=0.28, P=0.044). Independent POPF predictors included duct diameter ≤4 mm (OR 1.37, 95% CI: 1.03, 1.82), anticoagulation (OR 2.45, 95% CI: 1.47, 3.99), and indication other than PDAC (OR 2.33, 95% CI: 1.68, 3.27).CONCLUSIONSThis study establishes the first international benchmarks for robotic Whipple, demonstrating oncologic outcomes and morbidity comparable to open surgery with the benefits of minimally invasive surgery.","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":"49 1","pages":""},"PeriodicalIF":9.0,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146005322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-21DOI: 10.1097/sla.0000000000007016
Jon C Gould
{"title":"GERD Treatment Bias and the Underutilized Fundoplication.","authors":"Jon C Gould","doi":"10.1097/sla.0000000000007016","DOIUrl":"https://doi.org/10.1097/sla.0000000000007016","url":null,"abstract":"","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":"1 1","pages":""},"PeriodicalIF":9.0,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146005323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-21DOI: 10.1097/sla.0000000000007015
Neal E Seymour,Dmitry Nepomnayshy,Melissa N Hanson,Aurora D Pryor,Jacob A Greenberg,Brenessa Lindeman,Karen J Brasel
The "Fundamentals of Laparoscopic Surgery" (FLS) certification has been shown to establish achievement of basic levels of knowledge and skills competencies in laparoscopic surgery by surgical residents. Current evidence shows that this frequently occurs too late in training for residents to use these competencies to facilitate their advancement toward operative autonomy. The American Board of Surgery (ABS) General Surgery Board working with the Society of American Gastrointestinal and Endoscopic Surgeon (SAGES) FLS Committee have jointly formulated a recommendation that FLS certification should ideally be achieved by US surgical residents by the end of postgraduate year-2 in order to facilitate access to more advanced laparoscopic procedures and to achievement of practice readiness.
{"title":"A Recommendation for FLS Certification for General Surgery Residents By the End of the PGY-2 Year.","authors":"Neal E Seymour,Dmitry Nepomnayshy,Melissa N Hanson,Aurora D Pryor,Jacob A Greenberg,Brenessa Lindeman,Karen J Brasel","doi":"10.1097/sla.0000000000007015","DOIUrl":"https://doi.org/10.1097/sla.0000000000007015","url":null,"abstract":"The \"Fundamentals of Laparoscopic Surgery\" (FLS) certification has been shown to establish achievement of basic levels of knowledge and skills competencies in laparoscopic surgery by surgical residents. Current evidence shows that this frequently occurs too late in training for residents to use these competencies to facilitate their advancement toward operative autonomy. The American Board of Surgery (ABS) General Surgery Board working with the Society of American Gastrointestinal and Endoscopic Surgeon (SAGES) FLS Committee have jointly formulated a recommendation that FLS certification should ideally be achieved by US surgical residents by the end of postgraduate year-2 in order to facilitate access to more advanced laparoscopic procedures and to achievement of practice readiness.","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":"101 1","pages":""},"PeriodicalIF":9.0,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146005325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-16DOI: 10.1097/sla.0000000000007010
Andrew G Shuman,Anji Wall
{"title":"Revisiting Organ Donor Choice in the Circulatory Death Era.","authors":"Andrew G Shuman,Anji Wall","doi":"10.1097/sla.0000000000007010","DOIUrl":"https://doi.org/10.1097/sla.0000000000007010","url":null,"abstract":"","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":"57 1","pages":""},"PeriodicalIF":9.0,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145986559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-15DOI: 10.1097/sla.0000000000007011
Riccardo Guastella,Giampaolo Perri,Otto M van Delden,Jan-Fritjof Willemsen,Yuran Dai,Thomas F Stoop,Olivier R Busch,Yuping Shu,Fuye Lin,Poya Ghorbani,Zipeng Lu,Ernesto Sparrelid,Kuirong Jiang,Umberto Cillo,Marc G Besselink,Giovanni Marchegiani
OBJECTIVETo assess the impact of celiac axis stenosis (CAS) on postoperative outcome after pancreatoduodenectomy (PD) and total pancreatectomy (TP), and to describe treatment strategies based on CAS severity and etiology.SUMMARY BACKGROUND DATAAsymptomatic CAS may compromise hepatic and gastric perfusion after PD and TP, potentially increasing morbidity. The role of preoperative CAS detection and treatment remains unknown.METHODSInternational retrospective study at four high-volume centers in four countries (2018-2024). All preoperative CT imaging was re-assessed. CAS >50% stenosis was graded as B/C and considered clinically relevant. Etiology was classified as atherosclerotic, median arcuate ligament [MAL]-related, or mixed. Outcome was associated with CAS severity, etiology, and treatment. Standardized management protocols per center were identified.RESULTSAmong 1,698 patients undergoing PD and TP, CAS was identified in 16% (n=279). CAS grade B/C (6.5%, n=111) was independently associated with severe complications (OR 2.20, P<0.001), bile leak (OR 2.67, P=0.007), liver perfusion failure (OR 2.60, P<0.001), and gastric ischemia (OR 11.29, P<0.001). Outcomes differed by etiology: atherosclerotic CAS was associated with higher bile leak rate (22.7% vs. 5.7%; P=0.018) than MAL-related CAS. Centers with standardized protocols identified and treated CAS more frequently.CONCLUSIONSCAS grade B/C is an underrecognized yet potentially modifiable risk factor for severe complications after PD and TP. Preoperative identification of CAS grade B/C, including etiology, may allow targeted intervention but larger studies are required.
{"title":"Impact of Celiac Axis Stenosis in Patients Undergoing Pancreatoduodenectomy and Total Pancreatectomy: International Multicenter Study.","authors":"Riccardo Guastella,Giampaolo Perri,Otto M van Delden,Jan-Fritjof Willemsen,Yuran Dai,Thomas F Stoop,Olivier R Busch,Yuping Shu,Fuye Lin,Poya Ghorbani,Zipeng Lu,Ernesto Sparrelid,Kuirong Jiang,Umberto Cillo,Marc G Besselink,Giovanni Marchegiani","doi":"10.1097/sla.0000000000007011","DOIUrl":"https://doi.org/10.1097/sla.0000000000007011","url":null,"abstract":"OBJECTIVETo assess the impact of celiac axis stenosis (CAS) on postoperative outcome after pancreatoduodenectomy (PD) and total pancreatectomy (TP), and to describe treatment strategies based on CAS severity and etiology.SUMMARY BACKGROUND DATAAsymptomatic CAS may compromise hepatic and gastric perfusion after PD and TP, potentially increasing morbidity. The role of preoperative CAS detection and treatment remains unknown.METHODSInternational retrospective study at four high-volume centers in four countries (2018-2024). All preoperative CT imaging was re-assessed. CAS >50% stenosis was graded as B/C and considered clinically relevant. Etiology was classified as atherosclerotic, median arcuate ligament [MAL]-related, or mixed. Outcome was associated with CAS severity, etiology, and treatment. Standardized management protocols per center were identified.RESULTSAmong 1,698 patients undergoing PD and TP, CAS was identified in 16% (n=279). CAS grade B/C (6.5%, n=111) was independently associated with severe complications (OR 2.20, P<0.001), bile leak (OR 2.67, P=0.007), liver perfusion failure (OR 2.60, P<0.001), and gastric ischemia (OR 11.29, P<0.001). Outcomes differed by etiology: atherosclerotic CAS was associated with higher bile leak rate (22.7% vs. 5.7%; P=0.018) than MAL-related CAS. Centers with standardized protocols identified and treated CAS more frequently.CONCLUSIONSCAS grade B/C is an underrecognized yet potentially modifiable risk factor for severe complications after PD and TP. Preoperative identification of CAS grade B/C, including etiology, may allow targeted intervention but larger studies are required.","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":"8 1","pages":""},"PeriodicalIF":9.0,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145968387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-06DOI: 10.1097/sla.0000000000007008
Elizabeth Wall-Wieler,Shih-Hao Lee,Yuki Liu,Feibi Zheng
OBJECTIVETo determine the sensitivity of insurance claims codes in identifying robotic-assisted surgery (RAS), assess bias from misclassification, and evaluate the generalizability of findings across data sources.SUMMARY BACKGROUND DATAInsurer-generated databases are widely used to study RAS outcomes, but inconsistent use of claims codes may lead to misclassification and biased estimates.METHODSThis retrospective cohort study compared a test definition (claims only) to a reference definition (claims plus free-text hospital billing data) for identifying RAS from 2018-2023. Two U.S. datasets were used: the Premier Healthcare Database (PHD), a large hospital discharge database, and Merative™, a major claims database for insured employees and dependents. Seven procedures-inguinal hernia repair, cholecystectomy, sleeve gastrectomy, Roux-en-Y gastric bypass, lobectomy, right colectomy, and hysterectomy-were evaluated in inpatient and outpatient settings. Misclassification bias was assessed for operative time, length of stay, conversion to open surgery, and surgical site infection. Generalizability was examined by comparing RAS rates across datasets.RESULTSAmong 2,978,390 procedures in PHD, the sensitivity of claims-only identification was 0.578. Sensitivity exceeded 0.8 for all inpatient procedures across years but was very low for outpatient procedures, falling below 0.5 by 2021. For procedures commonly performed outpatient, effect estimates based on the claims-only definition were frequently biased. RAS rates using the test definition in PHD were generally higher than those observed in the claims-only Merative™ dataset.CONCLUSIONSensitivity of claims data to identify RAS varies by procedure, setting, and time. Low sensitivity causes substantial misclassification bias, impacting analyses of surgical modality and outcomes.
{"title":"Sensitivity of Insurance Claims Codes in Identifying Robotic Assisted Surgery.","authors":"Elizabeth Wall-Wieler,Shih-Hao Lee,Yuki Liu,Feibi Zheng","doi":"10.1097/sla.0000000000007008","DOIUrl":"https://doi.org/10.1097/sla.0000000000007008","url":null,"abstract":"OBJECTIVETo determine the sensitivity of insurance claims codes in identifying robotic-assisted surgery (RAS), assess bias from misclassification, and evaluate the generalizability of findings across data sources.SUMMARY BACKGROUND DATAInsurer-generated databases are widely used to study RAS outcomes, but inconsistent use of claims codes may lead to misclassification and biased estimates.METHODSThis retrospective cohort study compared a test definition (claims only) to a reference definition (claims plus free-text hospital billing data) for identifying RAS from 2018-2023. Two U.S. datasets were used: the Premier Healthcare Database (PHD), a large hospital discharge database, and Merative™, a major claims database for insured employees and dependents. Seven procedures-inguinal hernia repair, cholecystectomy, sleeve gastrectomy, Roux-en-Y gastric bypass, lobectomy, right colectomy, and hysterectomy-were evaluated in inpatient and outpatient settings. Misclassification bias was assessed for operative time, length of stay, conversion to open surgery, and surgical site infection. Generalizability was examined by comparing RAS rates across datasets.RESULTSAmong 2,978,390 procedures in PHD, the sensitivity of claims-only identification was 0.578. Sensitivity exceeded 0.8 for all inpatient procedures across years but was very low for outpatient procedures, falling below 0.5 by 2021. For procedures commonly performed outpatient, effect estimates based on the claims-only definition were frequently biased. RAS rates using the test definition in PHD were generally higher than those observed in the claims-only Merative™ dataset.CONCLUSIONSensitivity of claims data to identify RAS varies by procedure, setting, and time. Low sensitivity causes substantial misclassification bias, impacting analyses of surgical modality and outcomes.","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":"57 1","pages":""},"PeriodicalIF":9.0,"publicationDate":"2026-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145903570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2024-05-29DOI: 10.1097/SLA.0000000000006357
Sarah R Kaslow, Acacia R Sharma, D Brock Hewitt, John F P Bridges, Ammar A Javed, Christopher L Wolfgang, Scott Braithwaite, Greg D Sacks
Objective: We aimed to better understand patients' treatment preferences and quantify the level of cancer risk at which treatment preferences change (risk threshold) to inform better counseling of patients with intraductal papillary mucinous neoplasms (IPMNs).
Background: The complexity of IPMN management provides an opportunity to align treatment with individual preferences.
Methods: We surveyed a sample of healthy volunteers simulating a common scenario: undergoing an imaging study that incidentally identifies an IPMN. In the scenario, the estimated risk of cancer in the IPMN was 5%. Patients were asked about their treatment preference (surgery or surveillance) to quantify the level of cancer risk in the IPMN at which their treatment preference would change (ie, risk threshold) and their level of cancer anxiety as measured on a 5-point Likert scale. We examined associations between participant characteristics, treatment preferences, and risk threshold using multivariable linear regression.
Results: The median risk threshold among the 520 participants was 25% (IQR 2.3%-50%). The risk threshold had a bimodal distribution: 40% of participants had a risk threshold between 0% and 10%, and 47% had a risk threshold above 30%. When informed that the risk of cancer was 5%, 62% of participants (n=323) preferred surveillance, and the remaining 38% (n=197) preferred surgery. After adjusting for potential confounders, participants who expressed "worry" or "extreme worry" about the malignancy risk of IPMN had significantly lower risk thresholds than participants who were "not at all worried" (Coefficient -12, 95% CI: -21 to -2, P =0.015 and Coefficient -18, 95% CI -29 to -8, P <0.001, respectively).
Conclusions: Participants varied in treatment preference and risk threshold of incidentally identified IPMNs. Given the uncertainty in estimating the true malignant potential of IPMNs, a better understanding of a patient's risk threshold, as influenced by patient concern about malignancy, will help inform the shared decision-making process.
{"title":"Quantifying Patient Risk Threshold in Managing Pancreatic Intraductal Papillary Mucinous Neoplasms.","authors":"Sarah R Kaslow, Acacia R Sharma, D Brock Hewitt, John F P Bridges, Ammar A Javed, Christopher L Wolfgang, Scott Braithwaite, Greg D Sacks","doi":"10.1097/SLA.0000000000006357","DOIUrl":"10.1097/SLA.0000000000006357","url":null,"abstract":"<p><strong>Objective: </strong>We aimed to better understand patients' treatment preferences and quantify the level of cancer risk at which treatment preferences change (risk threshold) to inform better counseling of patients with intraductal papillary mucinous neoplasms (IPMNs).</p><p><strong>Background: </strong>The complexity of IPMN management provides an opportunity to align treatment with individual preferences.</p><p><strong>Methods: </strong>We surveyed a sample of healthy volunteers simulating a common scenario: undergoing an imaging study that incidentally identifies an IPMN. In the scenario, the estimated risk of cancer in the IPMN was 5%. Patients were asked about their treatment preference (surgery or surveillance) to quantify the level of cancer risk in the IPMN at which their treatment preference would change (ie, risk threshold) and their level of cancer anxiety as measured on a 5-point Likert scale. We examined associations between participant characteristics, treatment preferences, and risk threshold using multivariable linear regression.</p><p><strong>Results: </strong>The median risk threshold among the 520 participants was 25% (IQR 2.3%-50%). The risk threshold had a bimodal distribution: 40% of participants had a risk threshold between 0% and 10%, and 47% had a risk threshold above 30%. When informed that the risk of cancer was 5%, 62% of participants (n=323) preferred surveillance, and the remaining 38% (n=197) preferred surgery. After adjusting for potential confounders, participants who expressed \"worry\" or \"extreme worry\" about the malignancy risk of IPMN had significantly lower risk thresholds than participants who were \"not at all worried\" (Coefficient -12, 95% CI: -21 to -2, P =0.015 and Coefficient -18, 95% CI -29 to -8, P <0.001, respectively).</p><p><strong>Conclusions: </strong>Participants varied in treatment preference and risk threshold of incidentally identified IPMNs. Given the uncertainty in estimating the true malignant potential of IPMNs, a better understanding of a patient's risk threshold, as influenced by patient concern about malignancy, will help inform the shared decision-making process.</p>","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":" ","pages":"149-153"},"PeriodicalIF":6.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141174446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2024-07-25DOI: 10.1097/SLA.0000000000006457
Christopher Wirtalla, Caitlin B Finn, Rachael Acker, Sarah Landau, Solomiya Syvyk, Eric S Holmboe, Kenji Yamazaki, Rachel R Kelz
Objective: To establish whether the Accreditation Council for Graduate Medical Education Milestones predict the future performance of general surgery trainees.
Background: Milestones provide bi-annual assessments of trainee progress across 6 competencies. It is unknown whether the Milestones predict surgeon performance after the transition to independent practice.
Methods: We performed a retrospective cohort study of surgeons with complete Milestone assessments in the fourth and fifth clinical years who treated patients in acute care hospitals within Florida, New York, and Pennsylvania, 2015-2018. To account for the multiple ways in which the Milestone assessments might predict postgraduation outcomes, we included 120 Milestones features in our elastic net machine learning models. The primary outcome was risk-adjusted patient death or serious morbidity.
Results: A total of 278 general surgeons were included in the study. Milestone assessments 6 months into the fourth clinical year displayed a normal score distribution while multicollinearity and low score discrimination at the final assessment period were detected. Individual Milestones features from the Patient Care, Professionalism, and Systems-based Practice domains were most predictive of patient-related outcomes. For example, surgeons with worse patient outcomes had significantly lower scores in Patient Care 3 when compared with surgeons with better patient outcomes (high DSM, yes: 2.86 vs no: 3.04, P =0.011).
Conclusions: The Milestones features that were most predictive of better patient outcomes related to intraoperative skills, ethical principles, and patient navigation and safety measured 12 to 18 months before graduation. The development of a parsimonious set of evidence-based Milestones that better correlate with surgeon experience could enhance surgical education.
{"title":"The Predictive Performance of General Surgery Milestones on Postgraduation Outcomes.","authors":"Christopher Wirtalla, Caitlin B Finn, Rachael Acker, Sarah Landau, Solomiya Syvyk, Eric S Holmboe, Kenji Yamazaki, Rachel R Kelz","doi":"10.1097/SLA.0000000000006457","DOIUrl":"10.1097/SLA.0000000000006457","url":null,"abstract":"<p><strong>Objective: </strong>To establish whether the Accreditation Council for Graduate Medical Education Milestones predict the future performance of general surgery trainees.</p><p><strong>Background: </strong>Milestones provide bi-annual assessments of trainee progress across 6 competencies. It is unknown whether the Milestones predict surgeon performance after the transition to independent practice.</p><p><strong>Methods: </strong>We performed a retrospective cohort study of surgeons with complete Milestone assessments in the fourth and fifth clinical years who treated patients in acute care hospitals within Florida, New York, and Pennsylvania, 2015-2018. To account for the multiple ways in which the Milestone assessments might predict postgraduation outcomes, we included 120 Milestones features in our elastic net machine learning models. The primary outcome was risk-adjusted patient death or serious morbidity.</p><p><strong>Results: </strong>A total of 278 general surgeons were included in the study. Milestone assessments 6 months into the fourth clinical year displayed a normal score distribution while multicollinearity and low score discrimination at the final assessment period were detected. Individual Milestones features from the Patient Care, Professionalism, and Systems-based Practice domains were most predictive of patient-related outcomes. For example, surgeons with worse patient outcomes had significantly lower scores in Patient Care 3 when compared with surgeons with better patient outcomes (high DSM, yes: 2.86 vs no: 3.04, P =0.011).</p><p><strong>Conclusions: </strong>The Milestones features that were most predictive of better patient outcomes related to intraoperative skills, ethical principles, and patient navigation and safety measured 12 to 18 months before graduation. The development of a parsimonious set of evidence-based Milestones that better correlate with surgeon experience could enhance surgical education.</p>","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":" ","pages":"100-107"},"PeriodicalIF":6.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141756722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01Epub Date: 2025-06-12DOI: 10.1097/SLA.0000000000006782
Amanda Carlson, Jamie Hillas, Mary E Brindle, Yves Sonnay, Douglas S Smink, George Molina
{"title":"Redefining and Improving Patient Involvement in the Surgical Safety Checklist.","authors":"Amanda Carlson, Jamie Hillas, Mary E Brindle, Yves Sonnay, Douglas S Smink, George Molina","doi":"10.1097/SLA.0000000000006782","DOIUrl":"10.1097/SLA.0000000000006782","url":null,"abstract":"","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":" ","pages":"37-39"},"PeriodicalIF":6.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144273977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}